Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HER2-targeted therapies beyond breast cancer — an update
Jeesun Yoon, Do‐Youn Oh
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 9, pp. 675-700
Closed Access | Times Cited: 15

Showing 15 citing articles:

LMAN2 interacts with HEATR3 to expedite HER2-positive breast cancer advancement and inflammation and Akt/ERK/NF-κB signaling
Sujian Xiao, Tong Yu, Fulan Yang, et al.
Biochemistry and Cell Biology (2025)
Closed Access
Multifaceted Approaches in Epithelial Cell Adhesion Molecule-Mediated Circulating Tumor Cell Isolation
Dóra Szerényi, Gábor Járvás, András Guttman
Molecules (2025) Vol. 30, Iss. 5, pp. 976-976
Open Access
Tumor Microenvironment-Responsive Nanodrug for Embolotherapy and Enhanced Chemotherapy
Jialiang Zheng, Zhenhang Lin, Xi Li, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Leveraging HER2-targeted Biparatopic Antibodies in Solid Tumors
Xinlin Liu, Xinyi Fan, Xiang Gao, et al.
Pharmacological Research (2025) Vol. 214, pp. 107687-107687
Open Access
HER2-positive gastric cancer: from targeted therapy to CAR-T cell therapy
Qiang Shao, Junge Deng, Haoran Wu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Human Embryonic Kidney HEK293 Cells as a Model to Study SMVT-Independent Transport of Biotin and Biotin-Furnished Nanoparticles in Targeted Therapy
Magdalena Twardowska, Andrzej Łyskowski, Maria Misiorek, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1594-1594
Open Access
Dual‐Gating Strategy: Ultrasound Activation of TRPV2 Channels and Borate‐Glass‐Induced Calcium Overload for Tumor Suppression
Hai-Hong Zhu, Liping Ouyang, Yijie Huang, et al.
Advanced Science (2025)
Open Access
Multi-omics and drug development
Saira Hamid, Ajaz A. Bhat, Muzafar Rasool Bhat, et al.
Elsevier eBooks (2025), pp. 147-171
Closed Access
A standardized chamuangone enriched extract shows anticancer efficacy in allograft models of metastatic breast cancer
Asad Ur Rahman, Naveed Ullah Khan, Pharkphoom Panichayupakaranant, et al.
Journal of Functional Foods (2025) Vol. 127, pp. 106730-106730
Closed Access
PAI1 Regulates Cell Morphology and Migration Markers in Trastuzumab-Resistant HER2-Positive Breast Cancer Cells
Asiye Büşra Boz Er, İdris Er
Life (2024) Vol. 14, Iss. 8, pp. 1040-1040
Open Access | Times Cited: 2
CAF-Associated Genes in Breast Cancer for Novel Therapeutic Strategies
Kanako Naito, Takafumi Sangai, Keishi Yamashita
Biomedicines (2024) Vol. 12, Iss. 9, pp. 1964-1964
Open Access | Times Cited: 1
Choice of therapy for HER2-positive metastatic breast cancer in real clinical practice: analysis of physician preferences in Russian Federation
Е. В. Артамонова, E. V. Lubennikova
Medical alphabet (2024), Iss. 27, pp. 60-66
Closed Access | Times Cited: 1
Discovery of dual-targeted molecules based on Olaparib and Rigosertib for triple-negative breast cancer with wild-type BRCA
Zhikun Liu, Shining Mao, Lumei Dai, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 113, pp. 117936-117936
Closed Access
In Silico Design of Peptide Inhibitors Targeting HER2 for Lung Cancer Therapy
Heba Alkhatabi, Hisham N. Alatyb
Cancers (2024) Vol. 16, Iss. 23, pp. 3979-3979
Open Access
Small intestinal metastasis from primary breast cancer: a case report and review of literature
Fengqing Shen, Songxiang Wang, Shanlu Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Page 1

Scroll to top